Patrascu A, Tarca E, Lozneanu L, Ungureanu C, Morosan E, Parteni D
Diagnostics (Basel). 2025; 15(5).
PMID: 40075892
PMC: 11898898.
DOI: 10.3390/diagnostics15050644.
Li X, Sun L, Wu X, Qiu M, Ma X
Medicine (Baltimore). 2025; 104(10):e41653.
PMID: 40068078
PMC: 11902974.
DOI: 10.1097/MD.0000000000041653.
Khizar H, Ali K, Wang J
Cancer Immunol Immunother. 2025; 74(4):121.
PMID: 39998578
PMC: 11861851.
DOI: 10.1007/s00262-025-03965-w.
Arnold L, Yap M, Farrokhian N, Jackson L, Barry M, Ly T
Mol Cancer. 2025; 24(1):50.
PMID: 39994636
PMC: 11853957.
DOI: 10.1186/s12943-025-02264-3.
Glaviano A, Lau H, Carter L, Lee E, Lam H, Okina E
J Hematol Oncol. 2025; 18(1):6.
PMID: 39806516
PMC: 11733683.
DOI: 10.1186/s13045-024-01634-6.
Targeting Matrix Metalloproteinases and Their Inhibitors in Melanoma.
Szczygielski O, Dabrowska E, Niemyjska S, Przylipiak A, Zajkowska M
Int J Mol Sci. 2025; 25(24.
PMID: 39769318
PMC: 11676509.
DOI: 10.3390/ijms252413558.
The Hippo Pathway in Breast Cancer: The Extracellular Matrix and Hypoxia.
Yang H, Yang J, Zheng X, Chen T, Zhang R, Chen R
Int J Mol Sci. 2024; 25(23).
PMID: 39684583
PMC: 11641605.
DOI: 10.3390/ijms252312868.
Effects of Na1.5 and Rac1 on the Epithelial-Mesenchymal Transition in Breast Cancer.
Zha Z, Ge F, Li N, Zhang S, Wang C, Gong F
Cell Biochem Biophys. 2024; .
PMID: 39673684
DOI: 10.1007/s12013-024-01625-x.
Breaking the shield of solid tumors: a combined approach for enhanced efficacy of CAR-T cells.
Khaliulin M, Valiullina A, Petukhov A, Yuan Y, Spada S, Bulatov E
Cancer Immunol Immunother. 2024; 74(1):3.
PMID: 39487875
PMC: 11531461.
DOI: 10.1007/s00262-024-03817-z.
Translational insights into the hormetic potential of carbon dioxide: from physiological mechanisms to innovative adjunct therapeutic potential for cancer.
Gaspary J, Edgar L, Lopes L, Rosa C, Siluk J
Front Physiol. 2024; 15:1415037.
PMID: 39086932
PMC: 11288912.
DOI: 10.3389/fphys.2024.1415037.
Unveiling the power of flavonoids: A dynamic exploration of their impact on cancer through matrix metalloproteinases regulation.
Rajendran P
Biomedicine (Taipei). 2024; 14(2):12-28.
PMID: 38939095
PMC: 11204124.
DOI: 10.37796/2211-8039.1447.
Long noncoding RNAs HAND2-AS1 ultrasound microbubbles suppress hepatocellular carcinoma progression by regulating the miR-873-5p/tissue inhibitor of matrix metalloproteinase-2 axis.
Zou Q, Wang H, Di X, Li Y, Gao H
World J Gastrointest Oncol. 2024; 16(4):1547-1563.
PMID: 38660652
PMC: 11037064.
DOI: 10.4251/wjgo.v16.i4.1547.
DCLK1-Mediated Regulation of Invadopodia Dynamics and Matrix Metalloproteinase Trafficking Drives Invasive Progression in Head and Neck Squamous Cell Carcinoma.
Arnold L, Yap M, Jackson L, Barry M, Ly T, Morrison A
bioRxiv. 2024; .
PMID: 38645056
PMC: 11030349.
DOI: 10.1101/2024.04.06.588339.
Reprogramming of tumor-associated macrophages by metabolites generated from tumor microenvironment.
Kim S, Kim C, Moon Y, Kim H
Anim Cells Syst (Seoul). 2024; 28(1):123-136.
PMID: 38577621
PMC: 10993762.
DOI: 10.1080/19768354.2024.2336249.
Lung Inflammatory Phenotype in Mice Deficient in Fibulin-2 and ADAMTS-12.
Mohamedi Y, Fontanil T, Vega J, Cobo T, Cal S, Obaya A
Int J Mol Sci. 2024; 25(4).
PMID: 38396702
PMC: 10888546.
DOI: 10.3390/ijms25042024.
Tumor-Associated Macrophage Targeting of Nanomedicines in Cancer Therapy.
Kang X, Huang Y, Wang H, Jadhav S, Yue Z, Tiwari A
Pharmaceutics. 2024; 16(1).
PMID: 38258072
PMC: 10819517.
DOI: 10.3390/pharmaceutics16010061.
Cancer susceptibility 18 positively regulates NUAK Family Kinase 1 expression to promote migration and invasion via sponging of miR-5586-5p in cervical cancer cells.
Wang J, Zhang B, Gong S, Liu Y, Yi L, Long Y
Int J Immunopathol Pharmacol. 2023; 37:3946320231223310.
PMID: 38131232
DOI: 10.1177/03946320231223310.
Hypoxic Effects on Matrix Metalloproteinases' Expression in the Tumor Microenvironment and Therapeutic Perspectives.
Gonzalez-Avila G, Sommer B, Flores-Soto E, Aquino-Galvez A
Int J Mol Sci. 2023; 24(23).
PMID: 38069210
PMC: 10707261.
DOI: 10.3390/ijms242316887.
Depletion of slow-cycling PDGFRαADAM12 mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis.
Di Carlo S, Raffenne J, Varet H, Ode A, Cabrerizo Granados D, Stein M
Nat Immunol. 2023; 24(11):1867-1878.
PMID: 37798557
PMC: 10602852.
DOI: 10.1038/s41590-023-01642-7.
Correlation of Gene Expression Axis Changes with Treatment Efficacy and Survival of NSCLC Patients.
Pietrzak J, Wosiak A, Szmajda-Krygier D, Swiechowski R, Lochowski M, Pazik M
Biomedicines. 2023; 11(7).
PMID: 37509417
PMC: 10376864.
DOI: 10.3390/biomedicines11071777.